187 related articles for article (PubMed ID: 23525656)
1. Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).
Deng W; Dai CL; Chen JJ; Kathawala RJ; Sun YL; Chen HF; Fu LW; Chen ZS
Oncol Rep; 2013 Jun; 29(6):2479-85. PubMed ID: 23525656
[TBL] [Abstract][Full Text] [Related]
2. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
Shen T; Kuang YH; Ashby CR; Lei Y; Chen A; Zhou Y; Chen X; Tiwari AK; Hopper-Borge E; Ouyang J; Chen ZS
PLoS One; 2009 Oct; 4(10):e7520. PubMed ID: 19841739
[TBL] [Abstract][Full Text] [Related]
3. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS
PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321
[TBL] [Abstract][Full Text] [Related]
4. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance.
Kuang YH; Shen T; Chen X; Sodani K; Hopper-Borge E; Tiwari AK; Lee JW; Fu LW; Chen ZS
Biochem Pharmacol; 2010 Jan; 79(2):154-61. PubMed ID: 19720054
[TBL] [Abstract][Full Text] [Related]
5. PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter.
Chen JJ; Sun YL; Tiwari AK; Xiao ZJ; Sodani K; Yang DH; Vispute SG; Jiang WQ; Chen SD; Chen ZS
Cancer Sci; 2012 Aug; 103(8):1531-7. PubMed ID: 22578167
[TBL] [Abstract][Full Text] [Related]
6. CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10).
Wang JQ; Wang B; Teng QX; Lei ZN; Li YD; Shi Z; Ma LY; Liu HM; Liu Z; Chen ZS
Biochem Pharmacol; 2021 Aug; 190():114652. PubMed ID: 34126072
[TBL] [Abstract][Full Text] [Related]
7. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance.
Zhou Y; Hopper-Borge E; Shen T; Huang XC; Shi Z; Kuang YH; Furukawa T; Akiyama S; Peng XX; Ashby CR; Chen X; Kruh GD; Chen ZS
Biochem Pharmacol; 2009 Mar; 77(6):993-1001. PubMed ID: 19150344
[TBL] [Abstract][Full Text] [Related]
8. Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.
Sun YL; Chen JJ; Kumar P; Chen K; Sodani K; Patel A; Chen YL; Chen SD; Jiang WQ; Chen ZS
PLoS One; 2013; 8(2):e55576. PubMed ID: 23393594
[TBL] [Abstract][Full Text] [Related]
9. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.
Patel A; Tiwari AK; Chufan EE; Sodani K; Anreddy N; Singh S; Ambudkar SV; Stephani R; Chen ZS
Cancer Chemother Pharmacol; 2013 Jul; 72(1):189-99. PubMed ID: 23673445
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anticancer drug sensitivity in multidrug resistance cells overexpressing ATP-binding cassette (ABC) transporter ABCC10 by CP55, a synthetic derivative of 5-cyano-6-phenylpyrimidin.
Wang JQ; Wang B; Ma LY; Shi Z; Liu HM; Liu Z; Chen ZS
Exp Cell Res; 2021 Aug; 405(2):112728. PubMed ID: 34246653
[TBL] [Abstract][Full Text] [Related]
11. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
Kathawala RJ; Wei L; Anreddy N; Chen K; Patel A; Alqahtani S; Zhang YK; Wang YJ; Sodani K; Kaddoumi A; Ashby CR; Chen ZS
Oncotarget; 2015 Jan; 6(1):510-21. PubMed ID: 25402202
[TBL] [Abstract][Full Text] [Related]
12. PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR.
Anreddy N; Patel A; Sodani K; Kathawala RJ; Chen EP; Wurpel JN; Chen ZS
Acta Pharm Sin B; 2014 Jun; 4(3):202-7. PubMed ID: 26579384
[TBL] [Abstract][Full Text] [Related]
13. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS
Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007
[TBL] [Abstract][Full Text] [Related]
14. Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.
Kathawala RJ; Sodani K; Chen K; Patel A; Abuznait AH; Anreddy N; Sun YL; Kaddoumi A; Ashby CR; Chen ZS
Mol Cancer Ther; 2014 Mar; 13(3):714-23. PubMed ID: 24431074
[TBL] [Abstract][Full Text] [Related]
15. Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
Sun YL; Kumar P; Sodani K; Patel A; Pan Y; Baer MR; Chen ZS; Jiang WQ
Oncol Rep; 2014 Apr; 31(4):1605-12. PubMed ID: 24481648
[TBL] [Abstract][Full Text] [Related]
16. Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.
Ma SL; Hu YP; Wang F; Huang ZC; Chen YF; Wang XK; Fu LW
Mol Med; 2014 Sep; 20(1):390-9. PubMed ID: 25105301
[TBL] [Abstract][Full Text] [Related]
17. Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2.
Zhao XQ; Dai CL; Ohnuma S; Liang YJ; Deng W; Chen JJ; Zeng MS; Ambudkar SV; Chen ZS; Fu LW
Eur J Pharm Sci; 2013 Jun; 49(3):441-50. PubMed ID: 23619284
[TBL] [Abstract][Full Text] [Related]
18. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.
Hopper-Borge E; Xu X; Shen T; Shi Z; Chen ZS; Kruh GD
Cancer Res; 2009 Jan; 69(1):178-84. PubMed ID: 19118001
[TBL] [Abstract][Full Text] [Related]
19. Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.
Kathawala RJ; Wang YJ; Ashby CR; Chen ZS
Chin J Cancer; 2014 May; 33(5):223-30. PubMed ID: 24103790
[TBL] [Abstract][Full Text] [Related]
20. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]